Literature DB >> 27916611

Cytokine signatures in hereditary fever syndromes (HFS).

José Noel Ibrahim1, Isabelle Jéru2, Jean-Claude Lecron3, Myrna Medlej-Hashim4.   

Abstract

Hereditary fever syndromes (HFS) include a group of disorders characterized by recurrent self-limited episodes of fever accompanied by inflammatory manifestations occurring in the absence of infection or autoimmune reaction. Advances in the genetics of HFS have led to the identification of new gene families and pathways involved in the regulation of inflammation and innate immunity. The key role of several cytokine networks in the pathogenesis of HFS has been underlined by several groups, and supported by the rapid response of patients to targeted cytokine blocking therapies. This can be due to the direct effect of cytokine overproduction or to an absence of receptor antagonist resulting in dysbalance of downstream pro- and anti-inflammatory cytokine networks. The aim of this study was to present an overview and to discuss the major concepts regarding the cellular and molecular immunology of HFS, with a particular focus on their specific cytokine signatures and physiopathological implications. Based on their molecular and cellular mechanisms, HFS have been classified into intrinsic and extrinsic IL-1β activation disorders or inflammasomopathies, and protein misfolding disorders. This review integrates all recent data in an updated classification of HFS.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytokines; Hereditary fever syndromes; PBMC; Serum; Transcript; ex vivo

Mesh:

Substances:

Year:  2016        PMID: 27916611     DOI: 10.1016/j.cytogfr.2016.11.001

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  4 in total

1.  Serum IL 4 and its gene polymorphism (rs79071878) in Egyptian children with familial Mediterranean fever.

Authors:  Huda Marzouk; Yomna Farag; Hadeel M El-Hanafi; Eman Ibrahim
Journal:  Clin Rheumatol       Date:  2018-07-17       Impact factor: 2.980

2.  Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation.

Authors:  Erika Rimondi; Erica Valencic; Alberto Tommasini; Paola Secchiero; Elisabetta Melloni; Annalisa Marcuzzi
Journal:  Biomolecules       Date:  2021-09-30

3.  Reduced NLRP3 Gene Expression Limits the IL-1β Cleavage via Inflammasome in Monocytes from Severely Injured Trauma Patients.

Authors:  Shinwan Kany; Johann-Philipp Horstmann; Ramona Sturm; Katharina Mörs; Borna Relja
Journal:  Mediators Inflamm       Date:  2018-05-09       Impact factor: 4.711

Review 4.  Cytokines in Inflammatory Disease.

Authors:  Shinwan Kany; Jan Tilmann Vollrath; Borna Relja
Journal:  Int J Mol Sci       Date:  2019-11-28       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.